MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Arteriosclerosis | D001161 | 86 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Byrjalsen I et al. | Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium. | 2000 | BJOG | pmid:10740331 |
Alexandersen P et al. | Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects. | 2000 | BJOG | pmid:10740332 |
Cromie MA et al. | Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group. | 2000 | Contraception | pmid:10745070 |
Cagnacci A et al. | Transdermal administration of estradiol and norethisterone: effect on the uterus and uterine arteries. | 2000 Mar-Apr | Menopause | pmid:10746894 |
Shen Y et al. | Regulation of biodegradability and drug release behavior of aliphatic polyesters by blending. | 2000 | J. Biomed. Mater. Res. | pmid:10756311 |
Gravholt CH et al. | Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone. | 2000 | Atherosclerosis | pmid:10781652 |
Cooke I et al. | Antifibrinolytics for heavy menstrual bleeding. | 2000 | Cochrane Database Syst Rev | pmid:10796518 |
Lethaby A et al. | Cyclical progestogens for heavy menstrual bleeding. | 2000 | Cochrane Database Syst Rev | pmid:10796587 |
Lethaby AE et al. | Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. | 2000 | Cochrane Database Syst Rev | pmid:10796865 |
Stachenfeld NS et al. | Estrogen modifies the temperature effects of progesterone. | 2000 | J. Appl. Physiol. | pmid:10797125 |